Search results
Results from the WOW.Com Content Network
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.
The Secretary must also establish processes to: (1) provide waivers of requirements, including for undue economic hardship or emergency medical reasons; (2) provide exceptions to requirements relating to product identifiers if a product is packaged without sufficient space to bear the information; and (3) determine other products or ...
The 340B Program is often managed by software for maximizing the savings and for providing compliance. 340BSoftware.com is an example of such software. The Program is a federal program. The 340B Drug Pricing Program , administered by the Office of Pharmacy Affairs, resulted from enactment of Public Law 102-585, the Veterans Health Care Act of ...
According to the US Food and Drug Administration (FDA), an orphan drug is defined as one "intended for the treatment, prevention or diagnosis of a rare disease or condition, which is one that affects less than 200,000 persons in the US" (which equates to approximately 6 cases per 10,000 population) "or meets cost recovery provisions of the act".
James Stuart (1767) authored the first book in English with 'political economy' in its title, explaining it just as: . Economy in general [is] the art of providing for all the wants of a family, so the science of political economy seeks to secure a certain fund of subsistence for all the inhabitants, to obviate every circumstance which may render it precarious; to provide everything necessary ...
Economic evaluation is the process of systematic identification, measurement and valuation of the inputs and outcomes of two alternative activities, and the subsequent comparative analysis of these. [1] The purpose of economic evaluation is to identify the best course of action, based on the evidence available.
The original program had no training or reemployment component. The program was rarely used until 1974, when it was expanded as part of the Trade Act of 1974. The Trade Act of 1974 established the training component of the program. In 1981, the program was sharply curtailed by the Congress at the request of the Reagan Administration. [24]
Much of the edits seemed designed to remove any potentially negative information about the 340B drug discount program. I have replaced a good deal of my content, and reorganized the page in certain areas to clarify those items which are intended to shed light specifically about controversy over the program.